| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| A | 75ul | 75ul | 75ul | 75ul | 75ul | 75ul | 75ul | 75ul | 75ul | 75ul | 50ul | 50ul |
| B | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul |
| C | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | |
| D | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | |
| E | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | |
| F | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | |
| G | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | |
| H | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul |
2. A1 to A10 add 25ul of serum to be tested in each well, A11 plus 50ul of positive control, A12 plus 50ul of negative control, and mix well with a row of guns (6-7 times per well), 1 to 10 columns of serum to be tested are diluted from A to H in a row of 50ul in a row of 2 times, 1 column of positive control is diluted from A to H in a row of 50ul, and 2 columns of negative control are diluted from A to B in a row of 50ul.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| A | 25ul | 25ul | 25ul | 25ul | 25ul | 25ul | 25ul | 25ul | 25ul | 25ul | 50ul | 50ul |
| B | ||||||||||||
| C | ||||||||||||
| D | ||||||||||||
| E | ||||||||||||
| F | ||||||||||||
| G | ||||||||||||
| H |
3. After the dilution, the dilution ratio of each well is shown in the following table:
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| A | 1:04 | 1:04 | 1:04 | 1:04 | 1:04 | 1:04 | 1:04 | 1:04 | 1:04 | 1:04 | 1:16 | 1:02 |
| B | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:32 | 1:04 |
| C | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 0.08611 | |
| D | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 0.13056 | |
| E | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.21944 | |
| F | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.39722 | |
| G | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.75278 | |
| H | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 1.46389 |
4. Dilute the viral antigen according to the dilution ratio of the viral antigen indicated on the instructions in the kit, add 50ul of viral antigen per empty column from 1 to 11, add 50ul of viral antigen to A12 and B12, and add 100ul of viral antigen to E12, F12, G12 and H12.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| A | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul |
| B | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul |
| C | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | |
| D | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | |
| E | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 100ul |
| F | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 100ul |
| G | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 100ul |
| H | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 50ul | 100ul |
5. After the virus antigen is added, the dilution ratio of each well on the dilution plate changes, and the dilution ratio is as follows:
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| A | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:08 | 1:32 | 1:04 |
| B | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 1:16 | 0.08611 | 1:08 |
| C | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 1:32 | 0.13056 | |
| D | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.08611 | 0.21944 | |
| E | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.13056 | 0.39722 | |
| F | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.21944 | 0.75278 | |
| G | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 0.39722 | 1.46389 |
6. Place the sample serum dilution plate at 37°C for 2h.
Illustrated description of FMD liquid phase dosing operation (20 samples tested)
· A1-A10 plus 87.5ul of 1× PBST, A11, A12, B12 plus 50ul of 1× PBST, B1-B11, C1-C11, D1-D11, E1-E11, F1-F11, G1-G11, H1-H11 plus 50ul of 1× PBST.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| A | 87.5ul | 87.5ul | 87.5ul | 87.5ul | 87.5ul | 87.5ul |